"Fibromatosis, Aggressive" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A childhood counterpart of abdominal or extra-abdominal desmoid tumors, characterized by firm subcutaneous nodules that grow rapidly in any part of the body but do not metastasize. The adult form of abdominal fibromatosis is FIBROMATOSIS, ABDOMINAL. (Stedman, 25th ed)
| Descriptor ID |
D018222
|
| MeSH Number(s) |
C04.557.450.565.590.340.410
|
| Concept/Terms |
Fibromatosis, Aggressive- Fibromatosis, Aggressive
- Aggressive Fibromatoses
- Aggressive Fibromatosis
- Fibromatoses, Aggressive
- Desmoid
- Desmoids
|
Below are MeSH descriptors whose meaning is more general than "Fibromatosis, Aggressive".
Below are MeSH descriptors whose meaning is more specific than "Fibromatosis, Aggressive".
This graph shows the total number of publications written about "Fibromatosis, Aggressive" by people in this website by year, and whether "Fibromatosis, Aggressive" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2017 | 2 | 0 | 2 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fibromatosis, Aggressive" by people in Profiles.
-
A Timely Oral Option: Single-Agent Vinorelbine in Desmoid Tumors. Oncologist. 2020 12; 25(12):e2013-e2016.
-
Outcome of Primary Desmoid Tumors at All Anatomic Locations Initially Managed with Active Surveillance. Ann Surg Oncol. 2019 Dec; 26(13):4699-4706.
-
Desmoid fibromatosis through the patients' eyes: time to change the focus and organisation of care? Support Care Cancer. 2019 Mar; 27(3):965-980.
-
Pediatric sinonasal desmoid tumor. Ear Nose Throat J. 2017 Oct-Nov; 96(10-11):417-418.
-
Pazopanib, a promising option for the treatment of aggressive fibromatosis. Anticancer Drugs. 2017 04; 28(4):421-426.
-
Advanced aggressive fibromatosis: Effective palliation with chemotherapy. Acta Oncol. 2011 Apr; 50(3):455-61.
-
Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis. Eur J Cancer. 2009 Nov; 45(17):2930-4.